Charles Sternberg, Associate Editor02.07.23
OSSIO Inc., a fast-growing orthopedic fixation technology company, has introduced the OSSIOfiber Compression Staple. OSSIO’s fifth product family, OSSIOfiber Compression Staples, allow surgeons to evolve to stronger, bio-integrative compression.
Combined with OSSIO’s full line of bio-integrative orthopedic fixation products, OSSIOfiber Compression Staples allow the company to provide solutions for many midfoot and hindfoot procedures including Lapidus fusions, midfoot fusions and procedures associated with flatfoot correction.
OSSIOfiber provides a credible solution to the shortcomings of permanent metal hardware and conventional resorbable and allograft implants, combining mechanical strength and natural bone healing in a non-permanent implant.
Designed for predictable bone in-growth, regeneration and replacement, OSSIOfiber Intelligent Bone Regeneration Technology is a first-of-its-kind implant material stronger than cortical bone. OSSIOfiber is engineered to provide the strength required for functional fixation and allows for full integration into the native anatomy without adverse biological response. OSSIOfiber implants utilize existing reimbursement and surgical techniques.
“The benefits of OSSIOfiber are clear to both surgeons and patients, who prefer the bio-integrative technology and natural repair over metal and are demanding its use,” Brian Verrier, CEO of OSSIO, said. “OSSIO is excited to offer this additional product family so we can expand patient access to this technology.”
OSSIOfiber Compression Staples, received FDA 510(k) clearance in January 2022 for fixation of arthrodesis, osteotomies and fractures in hand or foot surgery in the presence of appropriate brace and/or immobilization.
OSSIOfiber Compression Staples provide stability and fixation, are stronger than many nitinol staples, and offer superior compression performance versus many widely used compression staples. With fatigue strength tested to over a million cycles, patients and surgeons can count on reliable strength that will last over time.
OSSIOfiber Compression Staples leave nothing behind but healthy bone, helping patients to avoid surgical removal and enabling surgeons to see fusion take place with artifact-free imaging. Patients also avoid long-term implant prominence, a problem many people experience with hardware that lies on top of the bone. Unlike nitinol staples, which contain more than 50 percent nickel, OSSIOfiber Compression Staples provide a nickel-free solution for metal sensitive patients.
Combined with OSSIO’s full line of bio-integrative orthopedic fixation products, OSSIOfiber Compression Staples allow the company to provide solutions for many midfoot and hindfoot procedures including Lapidus fusions, midfoot fusions and procedures associated with flatfoot correction.
About OSSIOfiber Compression Staples
Like all OSSIO implants, OSSIOfiber Compression Staples are made with OSSIOfiber Intelligent Bone Regeneration Technology, a proprietary bio-integrative mineral fiber matrix, providing surgeons with a biologically friendly way to restore patient stability and mobility while leaving no permanent hardware behind.OSSIOfiber provides a credible solution to the shortcomings of permanent metal hardware and conventional resorbable and allograft implants, combining mechanical strength and natural bone healing in a non-permanent implant.
Designed for predictable bone in-growth, regeneration and replacement, OSSIOfiber Intelligent Bone Regeneration Technology is a first-of-its-kind implant material stronger than cortical bone. OSSIOfiber is engineered to provide the strength required for functional fixation and allows for full integration into the native anatomy without adverse biological response. OSSIOfiber implants utilize existing reimbursement and surgical techniques.
“The benefits of OSSIOfiber are clear to both surgeons and patients, who prefer the bio-integrative technology and natural repair over metal and are demanding its use,” Brian Verrier, CEO of OSSIO, said. “OSSIO is excited to offer this additional product family so we can expand patient access to this technology.”
OSSIOfiber Compression Staples, received FDA 510(k) clearance in January 2022 for fixation of arthrodesis, osteotomies and fractures in hand or foot surgery in the presence of appropriate brace and/or immobilization.
OSSIOfiber Compression Staples provide stability and fixation, are stronger than many nitinol staples, and offer superior compression performance versus many widely used compression staples. With fatigue strength tested to over a million cycles, patients and surgeons can count on reliable strength that will last over time.
OSSIOfiber Compression Staples leave nothing behind but healthy bone, helping patients to avoid surgical removal and enabling surgeons to see fusion take place with artifact-free imaging. Patients also avoid long-term implant prominence, a problem many people experience with hardware that lies on top of the bone. Unlike nitinol staples, which contain more than 50 percent nickel, OSSIOfiber Compression Staples provide a nickel-free solution for metal sensitive patients.